[ad_1]
Merck, a science and know-how firm, has introduced a cooperation settlement with AMCM, a German additive manufacturing firm and sister firm to EOS. The partnership focuses on creating 3D printing know-how for pill manufacturing that meets Good Manufacturing Apply (GMP) requirements for medical trials, with plans to increase to industrial manufacturing later.
The collaboration will use powder mattress fusion strategies, the place a laser melts and fuses powder supplies layer by layer to create tablets. This method goals to make energetic pharmaceutical ingredient (API) formulation extra scalable whereas decreasing the necessity for pricey reformulations throughout drug growth and manufacturing processes.
“Our partnership with AMCM / EOS has the potential to revolutionize the way in which tablets are produced. It will likely be a large transfer in direction of digitalization of the business,” mentioned Isabel de Paoli, Chief Technique Officer at Merck. “Our purpose is to develop the economic software of this know-how, which we are going to make accessible for medical trials first, after which transfer to full digital options at industrial scale.”
Marie Langer, CEO of EOS, added, “We’re excited to help Merck on its innovation journey. This cooperation combines Merck’s formulation competences in Healthcare in addition to its excipient experience in Life Science with our long-standing additive manufacturing know-how. Collectively, we are going to assist make drug growth extra versatile and quicker.”
The businesses say the know-how might allow quicker and cheaper pill manufacturing. The long-term imaginative and prescient contains versatile native pill manufacturing that may be tailored to particular market necessities and particular person affected person wants.
The undertaking is being developed at Merck’s Innovation Heart in Darmstadt, Germany, the place groups work on scaling concepts that create new enterprise alternatives throughout Merck’s Healthcare, Life Science, and Efficiency Supplies divisions.
Supply: merckgroup.com
[ad_2]
